Intra-operative sensation during caesarean delivery under neuraxial anaesthesia: A prospective cohort study mapping sensory experiences.
Sharon Orbach-Zinger, Karam Azem, Maya Bar...
https://pubmed.ncbi.nlm.nih.gov/41221837/Actively Recruiting
Led by Columbia University · Updated on 2026-10-29
150
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to evaluate whether adding dexmedetomidine or clonidine, two alpha-2 adrenergic agonists, to the standard spinal anesthesia improves comfort for women undergoing cesarean delivery. The study focuses on reducing sensations of pulling, tugging, or pressure during the operation and explores whether these additions prolong anesthetic effects and reduce postoperative pain. This study responds to growing interest in enhancing the spinal anesthesia experience during cesarean delivery. Participants will receive one of three treatments 30 mcg clonidine plus standard spinal anesthetics bupivacaine, fentanyl, morphine, 4 mcg dexmedetomidine plus the same standard anesthetics, or the standard spinal anesthetics alone. These medications are administered intrathecally, directly into the spinal fluid, to assess their effects on intraoperative sensations and anesthesia duration. The study compares these groups to determine differences in comfort and side effects. During the study, participants will be monitored for intraoperative discomfort and other outcomes such as recovery quality, length of motor and sensory block, blood pressure changes, and side effects after surgery. Researchers will use scores like the Obstetric Quality of Recovery and track medication use and blood pressure within the first hours after surgery. The study includes careful safety monitoring and aims to complete data collection by May 2028.
CONDITIONS
Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery
R
Richard M Smiley, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Columbia University
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Clonidine added to spinal anesthesia | Dexmedetomidine added to spinal anesthesia | Standard intrathecal opioid adjuvant |
|---|---|---|---|
| What it is | Addition of intrathecal clonidine to spinal anesthesia during cesarean delivery | Addition of intrathecal dexmedetomidine to spinal anesthesia during cesarean delivery | Use of intrathecal opioid as current standard adjuvant in spinal anesthesia for cesarean delivery |
| Role in trial | Experimental adjuvant arm compared with control | Experimental adjuvant arm compared with control | Represents established clinical practice outside the trial |
| Primary use | To enhance spinal anesthesia effect during cesarean delivery | To enhance spinal anesthesia effect during cesarean delivery | To improve anesthesia and pain control during cesarean delivery |
| How it is given or performed | Single intrathecal injection of clonidine with spinal anesthesia at cesarean delivery | Single intrathecal injection of dexmedetomidine with spinal anesthesia at cesarean delivery | Typically single intrathecal opioid (e.g., fentanyl or morphine) added to spinal anesthesia |
| Evidence status (efficacy/safety) | Evidence suggests dexmedetomidine is more effective than clonidine in improving block onset and duration | Dexmedetomidine improves postoperative analgesia and reduces opioid use, but may increase hypotension risk | Neuraxial opioids effectively enhance analgesia during cesarean delivery |
| Important risks | Potential for hypotension and sedation | Associated with increased intraoperative hypotension | Known to cause nausea, pruritus, respiratory depression |
| Important limitations | Not yet widely adopted; safety and efficacy still being evaluated for cesarean use | Retrospective data with potential bias; off-label use; need for randomized confirmation | Opioid side effects may limit tolerability |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single surgical procedure day
Participants receive spinal anesthesia with either clonidine, dexmedetomidine, or standard anesthetics during cesarean delivery.
1 visit (in-person)
Duration - Up to 48 hours post-surgery
Participants are monitored after surgery for recovery quality, side effects, blood pressure, and other outcomes up to 48 hours.
Multiple assessments within 48 hours
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Sharon Orbach-Zinger, Karam Azem, Maya Bar...
https://pubmed.ncbi.nlm.nih.gov/41221837/Hermann S Fernandes, Fernando Bliacheriene, Thúlio M Vago...
https://pubmed.ncbi.nlm.nih.gov/29596102/E Takalo, M Karpala, X An...
https://pubmed.ncbi.nlm.nih.gov/41265256/Columbia University
Lead Sponsor